Vinge advises Schibsted in conjunction with investment in Savr

Vinge has advised Schibsted in conjunction with its investment in Savr AB. The investment round, which is headed by Schibsted, will cotribute SEK 162 million to the company. Savr is a fund platform which repays all fund commission to its customers.


Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024